Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial (Q34583699)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial |
scientific article |
Statements
1 reference
Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial (English)
1 reference
Bernard Escudier
1 reference
Jacques-Olivier Bay
1 reference
Sylvie Negrier
1 reference
David Perol
1 reference
Christine Chevreau
1 reference
Remy Delva
1 reference
Emmanuel Sevin
1 reference
Armelle Caty
1 reference
French Immunotherapy Intergroup
1 reference
1 December 2007
1 reference
1 reference
1 reference
Identifiers
1 reference